Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab

Dominguez-Mozo, MI; Perez-Perez, S; Villar, LM; Oliver-Martos, B; Villarrubia, N; Matesanz, F; Costa-Frossard, L; Pinto-Medel, MJ; Garcia-Sanchez, MI; Ortega-Madueno, I; Lopez-Lozano, L; Garcia-Martinez, A; Izquierdo, G; Fernandez, S; Alvarez-Cermeno, JC; Arroyo, R; Alvarez-Lafuente, R – 2020